Argentina Neurology Devices Market Analysis by Mordor Intelligence
The Argentina Neurology Devices Market size is projected to expand from USD 127.20 million in 2026 and USD 134.48 million in 2027 to USD 177.60 million by 2032, registering a CAGR of 5.72% between 2027 and 2032.
The COVID-19 outbreak temporarily disrupted neurological healthcare services in Argentina, leading to a decline in the utilization of neurology-related devices during the early stages of the pandemic. A study published in Frontiers in September 2021 reported that emergency department visits and outpatient appointments at a tertiary neurological center in Argentina dropped substantially during the initial COVID-19 period. This reduction in patient access and clinical activity adversely affected demand for neurology devices in the short term. However, with the restoration of routine healthcare services following the easing of pandemic-related restrictions, neurological care delivery has largely recovered across the country. Consequently, the Argentina neurology devices market is anticipated to witness steady growth over the forecast period.
The rising prevalence of neurological disorders such as Parkinson's disease, Alzheimer's disease, epilepsy, and brain diseases, among others, is the major factor driving the market growth. For instance, according to an article published by Frontiers in May 2022, Argentina is said to have a high prevalence of epilepsy and a study was conducted in the country which showed that the pooled prevalence rate of epilepsy was 5.3 per 1,000 for male patients and 7.1 per 1,000 for female patients.
Furthermore, according to the data updated by ClinicalTrials.gov in April 2023, there are currently 11 active clinical trials of dementia in Argentina. Thus, the rise in research and development in Argentina related to neurological disorders such as dementia is expected to boost market growth.
Overall, the growing burden of neurological conditions and ongoing advancements in neurological technologies are expected to support market expansion in Argentina over the forecast period. Nevertheless, limited access to specialized neurological care and uneven distribution of advanced healthcare infrastructure across certain regions may restrict the adoption of sophisticated neurology devices, posing a challenge to market growth.
Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.
Market Trends and Insights
Sacral Nerve Stimulation Devices Segment is Expected to Have a Significant Market Share Over the Forecast Period
Sacral nerve stimulation systems are increasingly being adopted in Argentina as a long-term management option for patients with urinary and bowel dysfunction who do not achieve adequate symptom control through conventional treatments. Rising preference for minimally invasive neuromodulation therapies, coupled with growing awareness among patients and healthcare professionals regarding their clinical benefits, is supporting demand for these devices. Additionally, improvements in implant technology, expanding access to specialized treatment centers, and a greater focus on improving patients' quality of life are expected to contribute to the growth of the sacral nerve stimulation segment during the forecast period.
According to an article published by PubMed Central in May 2022, a survey was conducted in various countries, including Argentina, where the majority of the respondents wanted to know about the current treatment options available for fecal incontinence. Thus, increasing awareness about fecal incontinence is expected to boost the usage of sacral nerve stimulation.
Furthermore, according to an article published by PubMed in January 2021, a study was conducted in Argentina, which showed that there is a high prevalence of stress urinary incontinence among Argentinian women. The article also stated that among the patients who were having stress urinary incontinence, the prevalence of uncomplicated stress urinary incontinence was 39%. Thus, the high burden of urinary incontinence in the country is expected to boost the adoption of sacral nerve stimulation devices. Moreover, the rising adult and geriatric population in the country is also expected to boost segment growth, as these diseases are mainly associated with these age groups.
Hence, the aforementioned factors, such as the rising prevalence of fecal incontinence and urinary incontinence and the rising adult and geriatric population, are expected to boost the segment growth during the forecast period of the study.
Deep Brain Stimulation Devices Segment is Expected to Have a Significant Growth Over the Forecast Period
The deep brain stimulation (DBS) devices segment is expected to witness sustained growth in Argentina, supported by increasing adoption of advanced neuromodulation therapies for the management of movement disorders and treatment-resistant neurological conditions. Greater awareness among neurologists and neurosurgeons, improving access to specialized care, and advancements in implantable stimulation technologies are contributing to wider clinical acceptance of DBS systems. These factors are anticipated to support segment expansion over the forecast period. Moreover, the rising prevalence of such neurological disorders in Argentina and the rising geriatric population is expected to boost the segment growth.
For instance, according to an article published by Frontiers in January 2023, a study was conducted in Argentina, which showed that there is a normal decline in spatial memory related to aging in older people, and this is dramatically increased in neuropathological conditions such as Alzheimer's disease (AD). This indicates that the high burden of Alzheimer's Disease (AD) in the elderly population of the country is expected to create opportunities for market players to market deep brain stimulation devices in the country for the early screening and treatment of AD, thereby propelling the market growth.
Furthermore, according to the data updated by ClinicalTrials.gov in April 2023, there are currently 2 active clinical trials for epilepsy in Argentina. Thus, the rise in research and development in Argentina related to neurological disorders such as epilepsy is expected to boost the segment growth.
Competitive Landscape
Market Concentration
Competition in Argentina's neurology devices sector is driven by the presence of numerous domestic and international vendors pursuing opportunities in the expanding neurological care landscape. Companies are differentiating themselves through next-generation neurotechnology, improved treatment capabilities, and user-friendly device designs. The steady flow of new product development initiatives and strategic investments continues to reshape the market's competitive dynamics. Some of the key market players are B. Braun SE, Medtronic PLC, Abbott Laboratories, Nihon Kohden Corporation, and Stryker Corporation, among others.
Argentina Neurology Devices Industry Leaders
-
Stryker Corporation
-
Medtronic PLC
-
Abbott Laboratories
-
Nihon Kohden Corporation
-
B.Braun SE
- *Disclaimer: Major Players sorted in no particular order
Argentina Neurology Devices Market Companies Covered in this Report
- B. Braun
- Stryker
- Medtronic
- Abbott Laboratories
- Johnson & Johnson
- Nihon Kohden
- Smiths Group
- Elekta
- Integra LifeSciences
Recent Industry Developments in Argentina Neurology Devices Market
- October 2022: An update was posted for a clinical trial for studying lateral cord magnetic stimulation for refractory spastic cerebral palsy in Argentina is expected to start in October 2023.
- April 2022: CereVasc, Inc. stated that the first patient had been treated in its clinical study of the eShunt System in patients with normal pressure hydrocephalus (NPH). A clinical trial was underway in Argentina to study minimally invasive treatment for NPH.
Argentina Neurology Devices Market Report Scope
As per the scope of the report, neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury. The Argentina Neurology Devices market is segmented by type of device (cerebrospinal fluid management device, interventional neurology device (interventional/surgical simulators, neuro thrombectomy devices, carotid artery stents, embolic coils, and support devices), neurosurgery device (neuro endoscopes, stereotactic systems, aneurysm clips, and other neurosurgery devices), neurostimulation device (spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, and other neurostimulation devices), and other type of devices). The report offers the value (in USD) for the above segments.
Segmentation Overview
| Cerebrospinal Fluid Management Devices | |
| Interventional Neurology Devices | Interventional/Surgical Simulators |
| Neurothrombectomy Devices | |
| Carotid Artery Stents | |
| Embolic Coils | |
| Support Devices | |
| Neurosurgery Devices | Neuroendoscopes |
| Stereotactic Systems | |
| Aneurysm Clips | |
| Other Neurosurgery Devices | |
| Neurostimulation Devices | Spinal Cord Stimulation Devices |
| Deep Brain Stimulation Devices | |
| Sacral Nerve Stimulation Devices | |
| Other Neurostimulation Devices | |
| Other Types of Devices |
| By Type of Device | Cerebrospinal Fluid Management Devices | |
| Interventional Neurology Devices | Interventional/Surgical Simulators | |
| Neurothrombectomy Devices | ||
| Carotid Artery Stents | ||
| Embolic Coils | ||
| Support Devices | ||
| Neurosurgery Devices | Neuroendoscopes | |
| Stereotactic Systems | ||
| Aneurysm Clips | ||
| Other Neurosurgery Devices | ||
| Neurostimulation Devices | Spinal Cord Stimulation Devices | |
| Deep Brain Stimulation Devices | ||
| Sacral Nerve Stimulation Devices | ||
| Other Neurostimulation Devices | ||
| Other Types of Devices | ||
Key Questions Answered in the Report
What is the current Argentina Neurology Devices Market size?
The Argentina Neurology Devices Market is projected to register a CAGR of 5.72% during the forecast period (2027-2032)
Who are the key players in Argentina Neurology Devices Market?
Stryker Corporation, Medtronic PLC, Abbott Laboratories, Nihon Kohden Corporation and B.Braun SE are the major companies operating in the Argentina Neurology Devices Market.
What years does this Argentina Neurology Devices Market cover?
The report covers the Argentina Neurology Devices Market historical market size for years: 2021, 2022, 2023, 2024, and 2025. The report also forecasts the Argentina Neurology Devices Market size for years: 2027, 2028, 2029, 2030, 2031, and 2032.